Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Novel Dual-labeled Peptide for Multimodal Imaging of EGFR with L858R Mutation.

Current radiopharmaceuticals - 1 Jan 2024

Kim Myoung Hyoun, Kim Seul-Gi, Kim Dae-Weung

Abstract excerpt

BACKGROUND: The development of molecular imaging agents targeting epidermal growth factor receptor (EGFR) with L858R mutation may help with the selection of non-small cell lung carcinoma (NSCLCL) patients who may benefit from EFGR tyrosine kinase inhibitor (TKI) therapy. OBJECTIVE: In this study, we developed 99mTc STHHYYP-GHEG-ECGK-tetramethylrhodamine (STHHYYP-ECGK-TAMRA) to target EGFR with L858R mutation in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Mice, Nude
Share to Molecular Imaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multimodal Imaging

Share to Peptides

Share to Radiopharmaceuticals

Share to Rhodamines

Share to Tissue Distribution

Source

Identifiers

PMID: 37849228
DOI: 10.2174/0118744710249198231002055810

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Novel Dual-labeled Peptide for Multimodal Imaging of EGFR with L858R Mutation.PMID 37849228Read ↗

⁹⁹mTc-HYNIC-MPG: a novel SPECT probe for targeting mutated EGFR.Semantic proximity Read ↗

Evaluation of 99mTc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC.Semantic proximity Read ↗

Identification of novel peptide ligands for the cancer-specific receptor mutation EFGRvIII using a mixture-based synthetic combinatorial library.Semantic proximity Read ↗

PET and SPECT Imaging of the EGFR Family (RTK Class I) in OncologySemantic proximity Read ↗

Investigation of positron emission tomography for pharmacological assessment of epidermal growth factor receptor-directed therapiesSemantic proximity Read ↗

Synthesis and Fundamental Evaluation of Radioiodinated Rociletinib (CO-1686) as a Probe to Lung Cancer with L858R/T790M Mutations of Epidermal Growth Factor Receptor (EGFR).Semantic proximity Read ↗

Development of a human epidermal growth factor derivative with EGFR-blocking and depleted biological activities: A comparative in vitro study using EGFR-positive breast cancer cells.Semantic proximity Read ↗

Pharmacokinetic analysis of 6-O-[18F]FEE for PET imaging of EGFR mutation.Semantic proximity Read ↗

Cancer Targeting Radiopeptidomimetics in Molecular Nuclear MedicineSemantic proximity Read ↗

New Developments in Peptide Receptor Radionuclide TherapySemantic proximity Read ↗

Synthesis and Comparative Evaluation of 177 Lu-labeled PEG and non-PEG variant peptides as HER2-targeting probesSemantic proximity Read ↗

Molecular imaging probes derived from natural peptidesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.